Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Index funds and bonds serve different roles in a diversified portfolio. This guide explains when index funds may be preferred over bonds and how to balance exposure.
25,248 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
As markets rally into mid-2026, analysts spotlight five stock setups where Wall Street sees the most upside, driven b...
A major capital shift is unfolding as chipmakers gain ground while hyperscalers slow. NVIDIA and Micron are set to be...
Warren Buffett unveils a sweeping update to his charitable giving, moving billions of dollars to four family-led foun...
CT3 pivots to a dedicated Storage Contracts model to scale its decentralized storage network. The move promises faste...
Alphabet faces a pivotal year as AI monetization expands and cloud momentum compounds. Traders watch how capital spen...
A 68-year-old with $850,000 traditional IRA could face a six-figure tax bill as required minimum distributions loom. ...
A bold forecast from Nvidia's founder centers on an AI spending boom. This article breaks down the rationale, the mat...
Lauren Sánchez Bezos is fueling a $34 million Bezos Earth Fund push to reinvent fabrics—from bacteria-grown fibers to...
The Trump administration has ordered regulators to end credits tied to idle-start/stop technology, shifting costs and...
You’ve bought a few rental properties, but the real work starts now. This guide delivers a step-by-step plan to optim...
A Tuesday pullback in COP shares left investors weighing oil prices, broker notes, and the long-term outlook for ener...